These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30189667)

  • 1. A Metabolomics Approach to Pharmacotherapy Personalization.
    Balashova EE; Maslov DL; Lokhov PG
    J Pers Med; 2018 Sep; 8(3):. PubMed ID: 30189667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacometabonomics and personalized medicine.
    Everett JR; Loo RL; Pullen FS
    Ann Clin Biochem; 2013 Nov; 50(Pt 6):523-45. PubMed ID: 23888060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication.
    Jian J; He D; Gao S; Tao X; Dong X
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacometabolomics informs Pharmacogenomics.
    Neavin D; Kaddurah-Daouk R; Weinshilboum R
    Metabolomics; 2016 Jul; 12(7):. PubMed ID: 27516730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision medicine for psychopharmacology: a general introduction.
    Shin C; Han C; Pae CU; Patkar AA
    Expert Rev Neurother; 2016 Jul; 16(7):831-9. PubMed ID: 27104961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy.
    Kantae V; Krekels EHJ; Esdonk MJV; Lindenburg P; Harms AC; Knibbe CAJ; Van der Graaf PH; Hankemeier T
    Metabolomics; 2017; 13(1):9. PubMed ID: 28058041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacometabonomics - the novel way to personalized drug therapy].
    Maslov DL; Balashova EE; Lokhov PG; Archakov AI
    Biomed Khim; 2017 Mar; 63(2):115-123. PubMed ID: 28414282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
    Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
    OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine.
    Everett JR
    Front Pharmacol; 2016; 7():297. PubMed ID: 27660611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine: from pharmacogenomics to pharmacoproteomics.
    Chambliss AB; Chan DW
    Clin Proteomics; 2016; 13():25. PubMed ID: 27708556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
    Mussap M; Loddo C; Fanni C; Fanos V
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacometabonomics in humans: a new tool for personalized medicine.
    Everett JR
    Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization.
    Trifonova OP; Maslov DL; Balashova EE; Urazgildeeva GR; Abaimov DA; Fedotova EY; Poleschuk VV; Illarioshkin SN; Lokhov PG
    Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32466249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
    Corona G; Rizzolio F; Giordano A; Toffoli G
    J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics as a tool for personalizing medicine: 2012 update.
    Sun J; Beger RD; Schnackenberg LK
    Per Med; 2013 Mar; 10(2):149-161. PubMed ID: 29758850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics.
    Aboel Dahab A; El-Hag D; Moutamed GM; Aboel Dahab S; Abuknesha R; Smith NW
    Cancer Chemother Pharmacol; 2016 Sep; 78(3):465-89. PubMed ID: 27061417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity.
    Oh J; Yi S; Gu N; Shin D; Yu KS; Yoon SH; Cho JY; Jang IJ
    Genomics Inform; 2018 Sep; 16(3):52-58. PubMed ID: 30309203
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    He C; Liu Y; Wang Y; Tang J; Tan Z; Li X; Chen Y; Huang Y; Chen X; Ouyang D; Zhou H; Peng J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1095():15-23. PubMed ID: 30041085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacometabonomics: The Prediction of Drug Effects Using Metabolic Profiling.
    Everett JR
    Handb Exp Pharmacol; 2019; 260():263-299. PubMed ID: 31823071
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.